Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-01

Shahedur Rahman

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

1 pubs

  • Antineoplastic Agents
  • Macrocyclic Compounds
  • Histone Deacetylase Inhibitors
  • Carbocyanines
  • Humans
  • Indocyanine Green
  • Infrared Rays
  • Cell Line, Tumor
  • Nanomedicine
  • Nanoparticles
  • MCF-7 Cells

Biography and Research Information

OverviewAI-generated summary

Shahedur Rahman's research focuses on the development of novel nanomedicines for cancer therapy. His work involves creating ionic nanomedicines that are responsive to near-infrared light, utilizing macrocyclic histone deacetylase inhibitors. This approach aims to enhance the efficacy of cancer treatment by enabling targeted drug delivery and activation within tumor cells. Rahman has collaborated with researchers Nawab Ali, Monowar Hossain, Mahfuzul Hassan, and Adeolu Oluremi on this work. His recent publication in 2026 details the design and potential application of these near-infrared-responsive nanomedicines.

Metrics

  • Publications: 1

Selected Publications

  • Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
    International Journal of Pharmaceutics DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

8 Collaborators 4 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics